Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.
Article Title
Epidemiological, Therapeutic, and Molecular Challenges of HIV in the Central African Republic: A Literature Review
Authored by
Laris Michael Danhouron Bejendo
National Laboratory of Clinical Biology and Public Health, Bangui, Central African Republic and University of Bangui, Central African Republic.
Héritier Lango
National Laboratory of Clinical Biology and Public Health, Bangui, Central African Republic and University of Bangui, Central African Republic.
Clotaire Donatien Rafai
National Laboratory of Clinical Biology and Public Health, Bangui, Central African Republic and University of Bangui, Central African Republic.
Wanh-Ingo Hereidebona
National Laboratory of Clinical Biology and Public Health, Bangui, Central African Republic and University of Bangui, Central African Republic.
Christelle Bobossi
National Laboratory of Clinical Biology and Public Health, Bangui, Central African Republic and University of Bangui, Central African Republic.
Coreta Baguida Bokia
National Laboratory of Clinical Biology and Public Health, Bangui, Central African Republic and University of Bangui, Central African Republic.
Moynam Heredeibona
National Laboratory of Clinical Biology and Public Health, Bangui, Central African Republic and University of Bangui, Central African Republic.
Boniface Koffi
National Laboratory of Clinical Biology and Public Health, Bangui, Central African Republic and University of Bangui, Central African Republic.
Ernest Lango-Yaya
National Laboratory of Clinical Biology and Public Health, Bangui, Central African Republic and University of Bangui, Central African Republic.